CIK 0000875320 · Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 043039129
- Phone
- 6173416393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,307,135
- in 1 filing, $6.3M under 10b5-1 plans
Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Kewalramani Reshma CEO & President | Sale 10b5-1 | −11,866 | $531.53 | $6.3M | 86,471 |
| 2026-07-02 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale 10b5-1 | −1,500 | $524.99 | $787K | 45,321 |
| 2026-07-02 | McKechnie Duncan EVP, Chief Commercial Officer | Sale 10b5-1 | −1,541 | $519.00 | $800K | 11,001 |
| 2026-07-01 | Liu Joy EVP and Chief Legal Officer | Sale 10b5-1 | −828 | $502.71 | $416K | 19,131 |
| 2026-06-26 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −596 | $482.50 | $288K | 15,337 |
| 2026-06-18 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −1,020 | $462.17 | $471K | 15,933 |
| 2026-06-15 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −4,062 | $450.00 | $1.8M | 16,953 |
| 2026-06-05 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −1,745 | $450.00 | $785K | 21,015 |
| 2026-06-01 | Liu Joy EVP and Chief Legal Officer | Sale 10b5-1 | −828 | $439.91 | $364K | 19,959 |
| 2026-05-29 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −1,974 | $450.00 | $888K | 22,760 |
| 2026-05-15 | Bunnage Mark E. EVP, Chief Scientific Officer | Sale 10b5-1 | −33 | $453.45 | $15K | 7,284 |
| 2026-05-15 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −1,354 | $453.45 | $614K | 24,734 |
| 2026-05-12 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −6,988 | $450.00 | $3.1M | 26,088 |
| 2026-05-04 | Bhatia Sangeeta N. Director | Sale 10b5-1 | −318 | $423.73 | $135K | 4,924 |
| 2026-05-01 | Liu Joy EVP and Chief Legal Officer | Sale 10b5-1 | −1,104 | $425.02 | $469K | 20,729 |
| 2026-04-01 | Liu Joy EVP and Chief Legal Officer | Sale 10b5-1 | −978 | $449.17 | $439K | 21,833 |
| 2026-03-27 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −2,329 | $450.95 | $1.1M | 33,076 |
| 2026-03-13 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −2,329 | $481.79 | $1.1M | 35,405 |
| 2026-03-11 | McKechnie Duncan EVP, Chief Commercial Officer | Sale 10b5-1 | −2,633 | $498.42 | $1.3M | 12,489 |
| 2026-03-04 | McKechnie Duncan EVP, Chief Commercial Officer | Sale 10b5-1 | −2,437 | $475.30 | $1.2M | 15,122 |
Page 1 of 4 · 70 trades